Lipopeptides are antifungal agents that inhibit cell wall beta-(1,3)-g
lucan biosynthesis in fungal organisms. A mutant resistant to lipopept
ides was generated by UV mutagenesis and characterized. The Candida al
bicans,ls mutant (LP3-1) was stable and showed resistance specificity
to a broad range of lipopeptides and certain glycolipid inhibitors. Ot
her antifungal agents with diverse modes of action had a normal minimu
m inhibitory concentration profile for LP3-1 compared with the wild-ty
pe strain (CCH 442). In the in vitro beta-(1,3)-glucan synthase assay,
both the lipopeptides and papulacandin-related agents had considerabl
y higher 50% inhibitory concentration values in the LP3-1 strain than
in the wild-type strain. In reconstitution assays, the resistance fact
or was associated with the integral membrane pellet rather than the pe
ripheral GTP-binding protein. The LP3-1 strain had a membrane lipid pr
ofile similar to that of the parent strain and was virulent in a murin
e model of systemic candidiasis. Taken together, these results indicat
e that the resistance factor is associated with the integral membrane
component of beta-(1,3)-glucan synthase. Lipopeptides are common antif
ungal agents encountered during screening of natural products. The LP3
-1 strain was resistant to natural product extracts known to contain v
arious lipopeptides. Thus, LP3-1 can be used in a dereplication assay.